NSB 0.00% 3.6¢ neuroscientific biopharmaceuticals ltd

Ann: Change of Director's Interest Notice - Uvarov, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 853 Posts.
    lightbulb Created with Sketch. 5
    Both Chairman/Acting CEO and former Executive Director (now NED) buying within days of each other...
    Pretty strong signal to me. Definitely something is up.

    They must be close to resolving their issues with initiating the Phase 1 study. This is a very promising drug. Shame they had some (probably somewhat self-induced) hiccups along the way.

    Once there's an indication Phase 1 can be initiated, this will rocket back to 20c+ in a blink!

    A.
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
(20min delay)
Last
3.6¢
Change
0.000(0.00%)
Mkt cap ! $5.205M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 214285 3.5¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 75583 1
View Market Depth
Last trade - 16.12pm 15/11/2024 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.